"Advanced Genomics APAC and CancerFree Biotech on Friday announced a memorandum of understanding to create a partnership focused on creating personalized treatment plans for cancer patients using next-generation sequencing and in vitro drug testing."
"Nonacus, has launched GALEASTM Tumor, a next generation sequencing (NGS) test that provides comprehensive genomic profiling of tumors, allowing clinicians to accurately diagnose cancers and tailor treatments."